James N Kochenderfer

13PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 17, 2026
Corticosteroids ameliorate CAR T-cell-induced cytokine-release syndrome without inhibiting multiple myeloma treatment.

Christina Amatya, Katherine A Weissler, Norris Lam

|Jun 03, 2024
Chimeric antigen receptor T cell therapy for autoimmune disease.

James B Chung, Jennifer N Brudno, Dominic Borie

|May 20, 2024
Current understanding and management of CAR T cell-associated toxicities.

Jennifer N Brudno, James N Kochenderfer

|Nov 08, 2023
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial.

Jennifer N Brudno, Danielle A Natrakul, Jeremiah Karrs

|Aug 17, 2023
Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial.

Yi Lin, Noopur S Raje, Jesús G Berdeja

|Apr 13, 2023
Long-term outcomes following CAR T cell therapy: what we know so far.

Kathryn M Cappell, James N Kochenderfer

Pageof 3

Frequent Collaborators

4 joint publications

Jennifer N Brudno

2 joint publications

George H Patterson

2 joint publications

Nathalie Scholler

2 joint publications

Raul Cachau